ArticleNeurocritical care2025

The Dipeptidyl Peptidase-4 Inhibitor Saxagliptin as a Candidate Treatment for Disorders of Consciousness: A Deep Learning and Retrospective Clinical Analysis.

Daniel Toker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.